Loading...

Tango Therapeutics, Inc.

TNGX•NASDAQ
Healthcare
Biotechnology
$25.77
$-0.10(-0.39%)
U.S. Market opens in 40h 37m

Tango Therapeutics, Inc. (TNGX) Stock Overview

Explore Tango Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3B
P/E Ratio-29.31
EPS (TTM)$-0.87
ROE-0.50%
Fundamental Analysis

AI Price Forecasts

1 Month$17.20
3 Months$20.93
1 Year Target$7.86

TNGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Tango Therapeutics, Inc. (TNGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -29.31 and a market capitalization of 3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.46%
5-Day Change
1.74%
1-Month Change
32.19%
3-Month Change
119.90%
6-Month Change
243.33%
Year-to-Date (YTD) Change
190.63%
1-Year Change
1663.70%
3-Year Change
627.40%
5-Year Change
130.53%
All-Time (Max) Change
151.71%

Contact Information

https://www.tangotx.com
857 320 4900
100 Binney Street, Boston, MA, 02142

Company Facts

155 Employees
IPO DateSep 3, 2020
CountryUS
Actively Trading

Frequently Asked Questions